hims novo nordisk - Search News

News

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers

The Motley Fool on MSN · 1h

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ending of its deal with Hims & Hers jeopardizes the healthcare platform's goal to lead the weight loss market.

CBS News on MSN · 19h

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Insider on MSN · 8h

Hims & Hers stock plunges after Novo Nordisk ends its brief partnership

The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its blockbuster drug Wegovy.

23hon MSN

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs" under the ...

16h

Novo Nordisk ends Wegovy sales on Hims & Hers over "deceptive marketing" Novo Nordisk said it will stop selling Wegovy on ...

22h

Hims & Hers Health Stock Is Tumbling Monday: What's Happening?

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Monday after Novo Nordisk A/S (NYSE:NVO) terminated its ...

Zacks Investment Research on MSN4d

Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now?

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock lately despite its ...

1don MSN

Novo Nordisk shares fall as obesity pipeline faces investor scrutiny

Shares in Novo Nordisk fell as much as 3.5% on Monday after detailed trial data on its experimental obesity drug CagriSema ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results